Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions
Sandra Schmitz(Cliniques Universitaires Saint-Luc), Jean-Pascal Machiels(Cliniques Universitaires Saint-Luc), Marc Hamoir(Cliniques Universitaires Saint-Luc), Robert I. Haddad(Broad Institute), Gregory T. Wolf(University of Michigan), Jan B. Vermorken(University of Antwerp), Kie Kian Ang(The University of Texas MD Anderson Cancer Center), Carlos Suárez(Hospital Universitario Central de Asturias)
Cited by 86
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926